The interaction was studied by differential scanning calorimetry dsc, 31p nuclear magnetic resonance spectroscopy nmr, inductively coupled plasma optical emission spectroscopy icpoes, and electrospray ionization mass spectrometry esims. Unfortunately, as discussed in this article, moderate doses of genotoxic drugs such as cisplatin typical of those achieved in the clinic often invoke a cytostaticdormancy rather than cytotoxicapoptosis response in solid tumourderived cell lines. Phosphorescent metal complexes as theranostic anticancer. Platinumdna adducts, which are formed following uptake of the drug into the nucleus of cells, activate several cellular processes that mediate the cytotoxicity of. May 01, 2009 the anticancer properties of two new fluorescent platinum ii compounds, cispta9opycl 2 and cispta9pypdmsocl 2 are described. Dinuclear platinum anticancer complexes with fluorescent n,nbis aminoalkyl1,4diaminoanthraquinones. Thus, the key to developing photoreduction platinum complexes was to shift this spontaneous cellular reduction process to photoinduced. Platinum anticancer drugs, chemical biology of chemical. Different drug targeting and delivery dtd strategies have been developed to prevent the shortcomings of platinum based chemotherapy. Over the past decade, experimental and clinical studies on platinum derived compounds have led to the development of potent anticancer drugs. Platinum dna adducts, which are formed following uptake of the drug into the nucleus of cells, activate several cellular processes that mediate the cytotoxicity of these platinum drugs.
A targeted and imageguided platinum prodrug conjugated with a photosensitizer with aggregationinduced emission aie characteristics was designed for realtime and in situ drug activation monitoring in cancer cells as well as combinational photodynamic chemotherapy against cisplatin resistant cancer cells. Our research investigates these early stages of action of platinum complexes. The process involves a series of phases and is called the cell cycle. Many mechanisms of cisplatin resistance have been proposed including changes in cellular uptake and efflux of the drug, increased detoxification of the drug, inhibition of apoptosis and increased dna repair. Biologic activity of some adriamycin nsc123127 derivatives. Firstly, platinum drugs were entrapped in the cavity of aft via a phinduced protein unfoldingrefolding process in the presence of their respective saturated solutions. Cisplatin is one of the most effective anticancer agents widely used in the. Development of chemotherapy with cellcycle inhibitors for. Systemic evaluation on the pharmacokinetics of platinum. During this time platinum based drugs have made a major contribution to cancer therapy with significant benefits for many patients. In recent years, this picture has increased in complexity, based on studies.
Molecular mechanisms of platinum resistance in ovarian cancer. A major sideeffect of platinum based anticancer drugs is damage to auditory hair cells 14. Chemotherapy drugs target cells at different phases of the cell cycle. Despite an expanding panel of pt drugs, tumor cell resistance to chemotherapy agents continues to pose a significant challenge in the management of these neoplasms. Wang d, lippard sjcellular processing of platinum anticancer. Chemotherapy works with the cell cycle every time any new cell is formed, it goes through a usual process to become a fully functioning or mature cell. Targeted drug delivery system for platinumbased anticancer drugs. Encapsulation of platinum based anticancer drugs in aft was completed by two steps as reported previously. The side effects of platinumbased chemotherapy drugs. The dna template for transcription is the major target for these. Arsenoplatins are adducts of two chemically important anticancer drugs, cisplatin and arsenic trioxide, that have a ptii bond to an asiii hydroxide center. Platinum has been reported to bind to several proteins, including ubiquitin, hsp90, gactin, and other cytoskeletal proteins 2, 2023. It is of excellent significance to individualize this treatment using distinct approaches to circumvent the resistance of platinum drugs in cancer patients. Despite most patients do have a major response to primary chemotherapy, about 2030% fail to respond or progress.
Request pdf wang d, lippard sjcellular processing of platinum anticancer drugs. Synthesis and characterization of platinumiv anticancer. This is commonly manifested by an extended apoptotic. A variety of tdds have been explored to improve the antitumor activity of ptbased drugs such as nanoparticle drug systems, polymer drug systems, drugs macrocyclic compounds systems, etc. Platinum based cancer drugs market size global industry. Given these 6, problems of platinum drugs, we were inspired to explore an effective. This leads to many limitations for the further studies on their pharmacology and toxicology. Cellular and molecular responses to cisplatin and uvc many preclinical anticancer drug discoveryoptimization strategies are based on the assumption that there is some degree of doselinearity in the various cellular and molecular responses to cytotoxic drugs that invoke genotoxicoxidative stress.
The underlying mechanisms are incredibly complicated. Crystal structures of 3, 4, 7, and 8 were obtained, which revealed that their structural conformations were influenced by. The clinically used platinum complexes are shown in figure 2. The resurgence of platinum based cancer chemotherapy. For some of these, the binding resulted in conformational changes and subsequent altered biologic function. Platinum anticancer drugs and photochemotherapeutic agents. Platinum drugs are among the most effective anticancer agents, but their mode of action is. Such cellular processing eventually leads to an inhibition of the replication or transcription machinery of the cell. Initial platinum responsiveness is high but the majority of cancer patients will eventually relapse with cisplatinresistant disease.
Lippard department of chemistry, massachusetts institute of technology, cambridge. Such knowledge of the cellular processing of cisplatin adducts with dna provides valuable clues for the rational design of more efficient. However, the intrinsic or acquired resistance severely limit the clinical application of platinum based treatment. Update on the development, mode of action and clinical applications of platinum anticancer drugs. Xray structure and mechanism of rna polymerase ii stalled at. Caco2, dld1, hct15, hct116, ls180, sw620, and widr cells were used. Platinum analogs includes cisplatin, oxaliplatin and carboplatin. Structural and mechanistic studies of anticancer platinum. Platinumbased drugs differentially affect the ultrastructure. Although platinum based drugs pbds are effective anticancer agents, responsive patients eventually become resistant. Multiple transporters participate in the active transport of platinum. Cellular processing of platinum anticancer drugs nature. Several cellular pathways are activated in response to this interaction, which include recognition by high.
The adducts of platinum dna may impede cellular process and lead to apoptosis of the cell. Nov 21, 2007 the aim of this study is to examine the factors affecting sensitivity to cisplatin, carboplatin, and oxaliplatin in human colorectal tumor cell lines. Characterization and cellular uptake of platinum anticancer. In various cancer cell lines, carboplatin shows less toxicity than cisplatin at. Cellular responses to cisplatininduced dna damage hindawi.
Systemic evaluation on the pharmacokinetics of platinumbased. The platinum based drugs cisplatin, carboplatin, and oxaliplatin belong to the most widely used chemotherapeutics in oncology, showing clinical efficacy against many solid tumors. Excision of these adducts and subsequent dna repair synthesis were monitored in plasmids. Pdf characterization and cellular uptake of platinum. Platinum based drugs typically form bifunctional intra or interstranddnacrosslinksbycovalentbondingtothen7 positionsof two guanosine residues, triggering a variety of cellular processes. Targeted drug delivery system tdds is a promising strategy for the research of novel ptbased anticancer drugs. Cisplatininduced dna damage activates various signaling pathways to. Over the last 30 years, a large number of platinum analogues has been synthesized to enlarge the spectrum of activity, overcome cellular resistance, andor reduce the toxicity of both first e. Platinum anticancer drugs, chemical biology of chemical biology. Lippard, cellular processing of platinum anticancer drugs. Full text metal complexes in cancer therapy an update from drug. Unlike cisplatin and oxaliplatin, which form dna crosslinks, pyriplatin binds dna in a monofunctional manner.
Therefore, we aim to assess the differential effects of pbds on bc ultrastructure. However, the therapeutic efficacy of platinum drugs is limited by serious side effects and the occurrence of inherent or acquired resistance of tumor cells. Chemistry and molecular biology of platinum anticancer drugs. Cellular responses to platinumbased anticancer drugs and. Cellular processing of platinum anticancer drugs pubmed.
Platinum drug tumor resistance has become a very difficult issue to be overcome. This article summarises the history of platinum agents in this field and indicates the current and possible future directions of. Arsenoplatin1 is a dual pharmacophore anticancer agent. Its binding to dna prevents replication and transcription which causes cell death. Despite its widespread use, we lack a comprehensive picture of global drug. Platinum based drugs are among the most active anticancer agents and have been widely used in the treatment of a variety of human tumors. Platinum based ptbased anticancer drugs have been recognised as one of the most effective drugs for clinical treatment of malignant tumors due to its unique mechanism of action and broad range of anticancer spectrum. Pdf platinumdna interactions and subsequent cellular. Current status for oral platinum iv anticancer drug development. Breast cancer bc is the most common cause of cancerrelated death worldwide. We suggest that these phasing phenomena may be central to the recognition and processing of platinum dna adducts in cancer cells treated with these drugs and possibly. A cd inhibitor, ubenimex, synergistically enhances the. Yet cellular processing of cisplatin or these mitochondria.
Some tumors have a natural or acquired resistance to one class of drugs and, by applying several, it is hoped that an effective reduction in tumor mass can be. But, there are still some limitations such as side effects, drug resistancecros. Cis platinum compounds cisplatin, cisptcl 2nh 3 2, also known as cisddp 1, figure 2 is perhaps the best known example of a small molecule metalcontaining drug. Screens of the nci60 human tumor cell lines reveal that arsenoplatin1 ap1, pt. Mar 24, 2005 cellular processing of platinum anticancer drugs. Cellular accumulation and dna platination of two new. Nrf2 enhances cell proliferation and resistance to. In the following experiments, doseresponse curves were obtained for oxoplatin, cisplatin, jm 216, and jm 149, either applied in native form or following exposure to 0.
Synthesis, antiproliferative activity in cancer cells and. Figure 2 from cellular processing of platinum anticancer. Chemistry and molecular biology of platinum anticancer drugs stephen j. Impactinnovation platinum ptbased drug is one of the most widely used and effective anticancer agents. Platinum anticancer drugs since cisplatin, the first fda approved ptii anticancer drug, went on the market in 1978, platinum anticancer drugs have been a great success. Cellular processing of platinum anticancer drugs semantic scholar. Sampson2 abstract preclinical and clinical development of agents that inhibit cell cycle progression have brought an understanding of the feasibility of targeting various cell cycle regulators in patients. Jul 01, 2009 encapsulation of platinum based anticancer drugs in aft was completed by two steps as reported previously. These specialized cells transduce sound stimuli into a neural signal but can be damaged or destroyed by chemical compounds known as ototoxins. Mar 26, 2021 itors, adaptive drug resistance is frequently caused by activation of other alternative pathways, including decreased drug transport, increased cellular detoxification, increased tolerance of dna adducts, and defects in the apoptotic cell death pathway 7. A series of trans platinum iv complexes with functionalized aromatic carboxylate ligands, cis,cis,transptnh32cl2co2c6h4r2 r h 3, pvinyl 4, pmethoxy 5, piodo 6, pcyano 7, or ocarboxyl 8 was synthesized and characterized by spectroscopic methods. Innovative platinum derived anticancer agents risk or. However, the efficacy of platinum based drugs is often compromised because of the substantial risk for severe toxicities, including neurotoxicity. Wang d, lippard sjcellular processing of platinum anticancer drugs.
Novel ratiometric fluorescent probe for studying cellular. We used three human lung cancer cell lines with different degrees of nrf2 activation. Platinum complexes as anticancer agents recent patents on anticancer drug discovery, 2006, vol. Platinum drugs for treating cancer metals in medicine. The history of the discovery and development of cisplatin remains a.
Cellular rna targeting by platinum ii anticancer therapeutics cisdiamminedichloroplatinum ii, or cisplatin, is a widely prescribed anticancer compound, currently one of only three platinum ii complexes fda approved for cancer treatment. Cisplatin is one of the most effective anticancer agents widely used in the treatment of solid tumors. Chemotherapy is intended to induce cancer cell death through apoptosis and other avenues. Cisplatin, carboplatin, and oxaliplatin are the common platinum based anticancer drugs widely used in the chemotherapeutic treatment of solid tumors in clinic. In the cell, recognition of the platinum lesion by the. Deactivation of platinum drugs by thiols, increased nucleotide excision repair of pt dna adducts, decreased mismatch repair, and defective apoptosis result in resistance to platinum therapy. Apart from cisplatin, anticancer pt complexes based on similar scaffolds have also been developed to target mitochondria. The action of platinum anticancer drugs is a multistep process involving uptake, activation, dna binding, and cellular responses. Cisplatin, carboplatin and oxaliplatin are platinum based drugs that are widely used in cancer chemotherapy. The cellular recognition and processing of monofunctionalintercalative dna adducts formed by ptclenlno32 p1a1. Their growth inhibition by platinum derivatives was evaluated with a wst1 assay utilizing succinate dehydrogenase activity. Cisplatin, carboplatin, and oxaliplatin anticancer drugs are commonly used to treat lung, colorectal, ovarian, breast, head and neck, and genitourinary cancers. L n2acridin9ylaminoethylnmethylpropionamidine, acridinium cation, a cytotoxic hybrid agent with potent anticancer activity, was studied. Cellular processing of platinum anticancer drugs semantic.
Pyriplatin, cis diamminepyridinechloroplatinumii, a platinum based antitumor drug candidate, is a cationic compound with anticancer properties in mice and is a substrate for organic cation transporters that facilitate oxaliplatin uptake. How cells respond to cisplatininduced dna damage plays a critical role in deciding cisplatin sensitivity. The platinum based drugs cisplatin, carboplatin and oxaliplatin are regularly prescribed in the treatment of cancer and while they are effective, their use is limited by their severe, doselimiting side effects also referred to as adverse effectsevents. Effect of pretreatment of the platinum compounds with acids 3. For many years, it was thought that uncharged platinum drugs entered cancerous cells through a process of passive diffusion. Comparative study of the mode of action of clinically. Background information regarding pdt, the photophysical and photochemical properties of metal complexes is provided, as well as notable examples of photoactivated metal complexes with biological activity.
It is generally considered as a cytotoxic drug which kills cancer cells by damaging dna and inhibiting dna synthesis. The complexes that illustrate the prominent strategies utilized in the development of. How chemotherapy drugs work american cancer society. The development of platinum resistance seems a dynamic process. These compounds are highly active against several human tumor cell lines, including human ovarian carcinoma sensitive and cisplatinresistant cell lines a2780 and a2780r. Kalayda gv, jansen baj, wielaard p, tanke hj, reedijk j. Understanding and improving platinum anticancer drugs. Platinum and goldbased drugs on cancer chen journal of. Jan 08, 2018 development of chemotherapy with cell cycle inhibitors for adult and pediatric cancer therapy christopher c. Platinum anticancer drug damage enforces a particular. Xray structure and mechanism of rna polymerase ii stalled. Nrf2 enhances cell proliferation and resistance to anticancer.
It plays a major role in the treatment of a variety of cancers. Cellular responses to platinumbased anticancer drugs and uvc. Cellular responses to platinumbased anticancer drugs. Anticancer characteristics and ototoxicity of platinumii. Frontiers the drugresistance mechanisms of five platinum. Platinum drugs, such as cisplatin, carboplatin and oxaliplatin, are the mainstay. Platinum neurotoxicity pharmacogenetics molecular cancer. Clinical application of platinum based anticancer drugs is largely limited by severe general toxicity and drug resistance. Drug delivery systems with tumortargeting potential are highly desired. In this study, therefore, the role of nrf2 in cancer cell proliferation and resistance to anticancer drugs was investigated. Platinum dna adducts, which are formed following uptake of the drug into the nucleus of cells, activate several cellular processes that mediate the cytotoxicity of. The drugresistance mechanisms of five platinumbased.
Platinum based anticancer agents have been widely used in the clinic to successfully treat many different types of cancer. Aug 10, 2020 platinum is usually given in combination with other drugs, commonly vinblastine and bleomycin for testicular cancer. During the process, platinum iv complexes have attracted scientists great attention and favor as it offers the opportunity to overcome some of the problems faced with cisplatin use. Their main mechanism of action is believed to be the induction of cancer cell apoptosis as a response to their covalent binding to dna. An antimetabolite is a chemical that inhibits the use of a metabolite, which is another chemical that is part of normal metabolism. Nhcch3o2clasoh2, the first representative of this novel class of anticancer agents, displays a superior activity profile relative to the parent. Prior to the mid 1960s, all of the drugs used for treating cancer were purely organic compounds, but the serendipitous discovery of the anticancer properties of a simple coordination compound, that later became known as cisplatin, opened new possibilities for cancer chemotherapy. Nfe2related factor 2 nrf2, a key transcription regulator for antioxidant and detoxification enzymes, is abundantly expressed in cancer cells. Cellular and molecular pharmacology of oxaliplatin1. Platinum complexes as anticancer agents bentham science. However, the comprehensive pharmacokinetics of platinum based anticancer drugs has not been fully understood yet. However, the efficacy and applicability of platinum drugs are heavily restricted by severe systemic toxicities and drug resistance.
Platinum based anticancer drugs occupy a crucial role in the treatment of various malignant tumours. Platinum and goldbased drugs on cancer chen journal. Cellular proteins form another nondna target of platinum drugs. While resistance of some cancers to pbds has been explored, the cellular responses of bc cells are not studied yet. This combination chemotherapy, as it is known, has several objectives. Platinum complexes have long been used as tumor therapeutic agents for their. Platinum based anticancer drugs such as cisplatin, cisdiamminedichloroplatinumii, are widely used and among the most effective antineoplastic treatments 1, 2. Neurotoxicity can result in both acute and chronic debilitation. Mechanism of the membrane interaction of polynuclear platinum. It has subsequently become a leading selling anticancer drug, being most effective against testicular, ovarian, and head and neck tumors. Direct imaging of the uptake of platinum anticancer agents. The interaction between phospholipids and polynuclear platinum drugs was studied as a mechanism model for cellular uptake of anticancer drugs. Cancer copyright 2021 exploiting the acquired vulnerability. Patients who initially respond to platinum based chemotherapy end up becoming resistant.
Factors affecting sensitivity to antitumor platinum. Current status for oral platinum iv anticancer drug. Feb 21, 2019 nus chemists have developed a novel ratiometric fluorescent probe for studying cellular activity of the clinically important anticancer drug cisplatin for next generation drug development. The six platinum anticancer drugs with marketing approval for the treatment of human. Mar 15, 2010 the anticancer activity of cisplatin and other platinum drugs is believed to arise from their interaction with dna. Targeting and delivery of platinumbased anticancer drugs.
Such substances are often similar in structure to the metabolite that they interfere with, such as the antifolates that interfere with the use of folic acid. Cellular accumulation and dna platination of two new platinum. Pdf a platinum prodrug conjugated with a photosensitizer. Platinumdna interactions and subsequent cellular processes. The molecular mechanisms of heptaplatin in cisplatinresistant cancer cell lines and the involvement of metallothionein were investigated. B, immunoblot analysis of protein lysate from dld1 cells treated as described for a and probed for expression of total parp. It is now 20 years since the publication of the antitumour activity of platinum compounds by barnett rosenberg and his colleagues. Platinum anticancer agents johnson matthey technology.
1085 1480 607 936 1047 539 852 795 1515 417 530 1256 181 325 528 172 458 336 235 1410 430 1013 241 1322 894 992 520 1309 646 672 1004 207 965